Bristol-Myers Squibb buy gerihouse
Zusammenfassung
Diese Einschätzung wurde am 22.07.15 mit einem Endkurs von 62,67 € beendet. Leichte Gewinne von 3,33 % verzeichnete die BUY Einschätzung von gerihouse. gerihouse hat 50% Zuversicht bei dieser EinschätzungRendite ohne Dividenden (%)
| Name | 1W | 1M | 1J | 3J |
|---|---|---|---|---|
| Bristol-Myers Squibb | -2,15 % | -2,15 % | -34,16 % | -21,50 % |
| iShares Core DAX® | 0,00 % | -2,06 % | 13,11 % | 16,68 % |
| iShares Nasdaq 100 | 0,63 % | -2,88 % | 37,74 % | 43,44 % |
| iShares Nikkei 225® | 1,57 % | -5,89 % | 19,59 % | 4,62 % |
| iShares S&P 500 | 0,33 % | -2,28 % | 27,74 % | 41,05 % |
Was spricht laut gerihouse für und gegen Bristol-Myers Squibb in den nächsten Jahren?
Pro
Kontra
Kommentare von gerihouse zu dieser Einschätzung
In der Diskussion Bristol-Myers Squibb diskutieren
Nimm das Krebs!
Bristol-Myers Squibb beobachte ich schon längerm, und ich finde es ist an der Zeit eine Buy Empfehlung zu schreiben. Quartalsdividende gibt es Anfang Mai.
Bristol-Myers Squibb (NYSE:BMY) had its price target increased by Credit Suisse from $68.00 to $70.00 in a research report sent to investors on Thursday morning. The firm currently has an outperform rating on the stock.
Bristol-Myers Squibb traded up 0.55% on Thursday, hitting $65.48. The stock had a trading volume of 1,767,733 shares. Bristol-Myers Squibb has a 52 week low of $46.30 and a 52 week high of $67.18. The stock’s 50-day moving average is $61.24 and its 200-day moving average is $56.69. The company has a market cap of $108.8 billion and a price-to-earnings ratio of 54.27.
Bristol-Myers Squibb (NYSE:BMY) last released its earnings data on Tuesday, January 27th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.41 by $0.05. The company had revenue of $4.26 billion for the quarter, compared to the consensus estimate of $4.02 billion. During the same quarter in the prior year, the company posted $0.51 earnings per share. The company’s quarterly revenue was down 4.1% on a year-over-year basis. Analysts expect that Bristol-Myers Squibb will post $1.72 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Monday, April 6th will be paid a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 2.27%. The ex-dividend date is Wednesday, April 1st.
